Report Detail
Global Neuroprotection Sales Market Report 2018
- RnM1773580 |
- 21 March, 2018 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
In this report, the global Neuroprotection market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Neuroprotection for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India
Global Neuroprotection market competition by top manufacturers/players, with Neuroprotection sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Daiichi Sankyo Company
Eli Lilly and Company
Allergan
Dr. Reddy’s Laboratories
Teva Pharmaceutical
Novartis
AstraZeneca
Astrocyte Pharmaceuticals
F. Hoffmann-La Roche
Biogen
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Free Radical Trapping Agents (Antioxidants)
Glutamate Antagonists (Anti-Excitotoxic Agents)
Apoptosis Inhibitors
Anti-inflammatory Agents
Neurotrophic Factors (NTFs)
Metal Ion Chelators
Stimulants
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Prevention
Treatment
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Neuroprotection Sales Market Report 2018
1 Neuroprotection Market Overview
- 1.1 Product Overview and Scope of Neuroprotection
- 1.2 Classification of Neuroprotection by Product Category
- 1.2.1 Global Neuroprotection Market Size (Sales) Comparison by Type (2013-2025)
- 1.2.2 Global Neuroprotection Market Size (Sales) Market Share by Type (Product Category) in 2017
- 1.2.3 Free Radical Trapping Agents (Antioxidants)
- 1.2.4 Glutamate Antagonists (Anti-Excitotoxic Agents)
- 1.2.5 Apoptosis Inhibitors
- 1.2.6 Anti-inflammatory Agents
- 1.2.7 Neurotrophic Factors (NTFs)
- 1.2.8 Metal Ion Chelators
- 1.2.9 Stimulants
- 1.2.10 Others
- 1.3 Global Neuroprotection Market by Application/End Users
- 1.3.1 Global Neuroprotection Sales (Volume) and Market Share Comparison by Application (2013-2025)
- 1.3.2 Prevention
- 1.3.3 Treatment
- 1.4 Global Neuroprotection Market by Region
- 1.4.1 Global Neuroprotection Market Size (Value) Comparison by Region (2013-2025)
- 1.4.2 United States Neuroprotection Status and Prospect (2013-2025)
- 1.4.3 China Neuroprotection Status and Prospect (2013-2025)
- 1.4.4 Europe Neuroprotection Status and Prospect (2013-2025)
- 1.4.5 Japan Neuroprotection Status and Prospect (2013-2025)
- 1.4.6 Southeast Asia Neuroprotection Status and Prospect (2013-2025)
- 1.4.7 India Neuroprotection Status and Prospect (2013-2025)
- 1.5 Global Market Size (Value and Volume) of Neuroprotection (2013-2025)
- 1.5.1 Global Neuroprotection Sales and Growth Rate (2013-2025)
- 1.5.2 Global Neuroprotection Revenue and Growth Rate (2013-2025)
2 Global Neuroprotection Competition by Players/Suppliers, Type and Application
- 2.1 Global Neuroprotection Market Competition by Players/Suppliers
- 2.1.1 Global Neuroprotection Sales and Market Share of Key Players/Suppliers (2013-2018)
- 2.1.2 Global Neuroprotection Revenue and Share by Players/Suppliers (2013-2018)
- 2.2 Global Neuroprotection (Volume and Value) by Type
- 2.2.1 Global Neuroprotection Sales and Market Share by Type (2013-2018)
- 2.2.2 Global Neuroprotection Revenue and Market Share by Type (2013-2018)
- 2.3 Global Neuroprotection (Volume and Value) by Region
- 2.3.1 Global Neuroprotection Sales and Market Share by Region (2013-2018)
- 2.3.2 Global Neuroprotection Revenue and Market Share by Region (2013-2018)
- 2.4 Global Neuroprotection (Volume) by Application
3 United States Neuroprotection (Volume, Value and Sales Price)
- 3.1 United States Neuroprotection Sales and Value (2013-2018)
- 3.1.1 United States Neuroprotection Sales and Growth Rate (2013-2018)
- 3.1.2 United States Neuroprotection Revenue and Growth Rate (2013-2018)
- 3.1.3 United States Neuroprotection Sales Price Trend (2013-2018)
- 3.2 United States Neuroprotection Sales Volume and Market Share by Players (2013-2018)
- 3.3 United States Neuroprotection Sales Volume and Market Share by Type (2013-2018)
- 3.4 United States Neuroprotection Sales Volume and Market Share by Application (2013-2018)
4 China Neuroprotection (Volume, Value and Sales Price)
- 4.1 China Neuroprotection Sales and Value (2013-2018)
- 4.1.1 China Neuroprotection Sales and Growth Rate (2013-2018)
- 4.1.2 China Neuroprotection Revenue and Growth Rate (2013-2018)
- 4.1.3 China Neuroprotection Sales Price Trend (2013-2018)
- 4.2 China Neuroprotection Sales Volume and Market Share by Players (2013-2018)
- 4.3 China Neuroprotection Sales Volume and Market Share by Type (2013-2018)
- 4.4 China Neuroprotection Sales Volume and Market Share by Application (2013-2018)
5 Europe Neuroprotection (Volume, Value and Sales Price)
- 5.1 Europe Neuroprotection Sales and Value (2013-2018)
- 5.1.1 Europe Neuroprotection Sales and Growth Rate (2013-2018)
- 5.1.2 Europe Neuroprotection Revenue and Growth Rate (2013-2018)
- 5.1.3 Europe Neuroprotection Sales Price Trend (2013-2018)
- 5.2 Europe Neuroprotection Sales Volume and Market Share by Players (2013-2018)
- 5.3 Europe Neuroprotection Sales Volume and Market Share by Type (2013-2018)
- 5.4 Europe Neuroprotection Sales Volume and Market Share by Application (2013-2018)
6 Japan Neuroprotection (Volume, Value and Sales Price)
- 6.1 Japan Neuroprotection Sales and Value (2013-2018)
- 6.1.1 Japan Neuroprotection Sales and Growth Rate (2013-2018)
- 6.1.2 Japan Neuroprotection Revenue and Growth Rate (2013-2018)
- 6.1.3 Japan Neuroprotection Sales Price Trend (2013-2018)
- 6.2 Japan Neuroprotection Sales Volume and Market Share by Players (2013-2018)
- 6.3 Japan Neuroprotection Sales Volume and Market Share by Type (2013-2018)
- 6.4 Japan Neuroprotection Sales Volume and Market Share by Application (2013-2018)
7 Southeast Asia Neuroprotection (Volume, Value and Sales Price)
- 7.1 Southeast Asia Neuroprotection Sales and Value (2013-2018)
- 7.1.1 Southeast Asia Neuroprotection Sales and Growth Rate (2013-2018)
- 7.1.2 Southeast Asia Neuroprotection Revenue and Growth Rate (2013-2018)
- 7.1.3 Southeast Asia Neuroprotection Sales Price Trend (2013-2018)
- 7.2 Southeast Asia Neuroprotection Sales Volume and Market Share by Players (2013-2018)
- 7.3 Southeast Asia Neuroprotection Sales Volume and Market Share by Type (2013-2018)
- 7.4 Southeast Asia Neuroprotection Sales Volume and Market Share by Application (2013-2018)
8 India Neuroprotection (Volume, Value and Sales Price)
- 8.1 India Neuroprotection Sales and Value (2013-2018)
- 8.1.1 India Neuroprotection Sales and Growth Rate (2013-2018)
- 8.1.2 India Neuroprotection Revenue and Growth Rate (2013-2018)
- 8.1.3 India Neuroprotection Sales Price Trend (2013-2018)
- 8.2 India Neuroprotection Sales Volume and Market Share by Players (2013-2018)
- 8.3 India Neuroprotection Sales Volume and Market Share by Type (2013-2018)
- 8.4 India Neuroprotection Sales Volume and Market Share by Application (2013-2018)
9 Global Neuroprotection Players/Suppliers Profiles and Sales Data
- 9.1 Daiichi Sankyo Company
- 9.1.1 Company Basic Information, Manufacturing Base and Competitors
- 9.1.2 Neuroprotection Product Category, Application and Specification
- 9.1.2.1 Product A
- 9.1.2.2 Product B
- 9.1.3 Daiichi Sankyo Company Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.1.4 Main Business/Business Overview
- 9.2 Eli Lilly and Company
- 9.2.1 Company Basic Information, Manufacturing Base and Competitors
- 9.2.2 Neuroprotection Product Category, Application and Specification
- 9.2.2.1 Product A
- 9.2.2.2 Product B
- 9.2.3 Eli Lilly and Company Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.2.4 Main Business/Business Overview
- 9.3 Allergan
- 9.3.1 Company Basic Information, Manufacturing Base and Competitors
- 9.3.2 Neuroprotection Product Category, Application and Specification
- 9.3.2.1 Product A
- 9.3.2.2 Product B
- 9.3.3 Allergan Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.3.4 Main Business/Business Overview
- 9.4 Dr. Reddy’s Laboratories
- 9.4.1 Company Basic Information, Manufacturing Base and Competitors
- 9.4.2 Neuroprotection Product Category, Application and Specification
- 9.4.2.1 Product A
- 9.4.2.2 Product B
- 9.4.3 Dr. Reddy’s Laboratories Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.4.4 Main Business/Business Overview
- 9.5 Teva Pharmaceutical
- 9.5.1 Company Basic Information, Manufacturing Base and Competitors
- 9.5.2 Neuroprotection Product Category, Application and Specification
- 9.5.2.1 Product A
- 9.5.2.2 Product B
- 9.5.3 Teva Pharmaceutical Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.5.4 Main Business/Business Overview
- 9.6 Novartis
- 9.6.1 Company Basic Information, Manufacturing Base and Competitors
- 9.6.2 Neuroprotection Product Category, Application and Specification
- 9.6.2.1 Product A
- 9.6.2.2 Product B
- 9.6.3 Novartis Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.6.4 Main Business/Business Overview
- 9.7 AstraZeneca
- 9.7.1 Company Basic Information, Manufacturing Base and Competitors
- 9.7.2 Neuroprotection Product Category, Application and Specification
- 9.7.2.1 Product A
- 9.7.2.2 Product B
- 9.7.3 AstraZeneca Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.7.4 Main Business/Business Overview
- 9.8 Astrocyte Pharmaceuticals
- 9.8.1 Company Basic Information, Manufacturing Base and Competitors
- 9.8.2 Neuroprotection Product Category, Application and Specification
- 9.8.2.1 Product A
- 9.8.2.2 Product B
- 9.8.3 Astrocyte Pharmaceuticals Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.8.4 Main Business/Business Overview
- 9.9 F. Hoffmann-La Roche
- 9.9.1 Company Basic Information, Manufacturing Base and Competitors
- 9.9.2 Neuroprotection Product Category, Application and Specification
- 9.9.2.1 Product A
- 9.9.2.2 Product B
- 9.9.3 F. Hoffmann-La Roche Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.9.4 Main Business/Business Overview
- 9.10 Biogen
- 9.10.1 Company Basic Information, Manufacturing Base and Competitors
- 9.10.2 Neuroprotection Product Category, Application and Specification
- 9.10.2.1 Product A
- 9.10.2.2 Product B
- 9.10.3 Biogen Neuroprotection Sales, Revenue, Price and Gross Margin (2013-2018)
- 9.10.4 Main Business/Business Overview
10 Neuroprotection Maufacturing Cost Analysis
- 10.1 Neuroprotection Key Raw Materials Analysis
- 10.1.1 Key Raw Materials
- 10.1.2 Price Trend of Key Raw Materials
- 10.1.3 Key Suppliers of Raw Materials
- 10.1.4 Market Concentration Rate of Raw Materials
- 10.2 Proportion of Manufacturing Cost Structure
- 10.2.1 Raw Materials
- 10.2.2 Labor Cost
- 10.2.3 Manufacturing Process Analysis of Neuroprotection
- 10.3 Manufacturing Process Analysis of Neuroprotection
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
- 11.1 Neuroprotection Industrial Chain Analysis
- 11.2 Upstream Raw Materials Sourcing
- 11.3 Raw Materials Sources of Neuroprotection Major Manufacturers in 2017
- 11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
- 12.1 Marketing Channel
- 12.1.1 Direct Marketing
- 12.1.2 Indirect Marketing
- 12.1.3 Marketing Channel Development Trend
- 12.2 Market Positioning
- 12.2.1 Pricing Strategy
- 12.2.2 Brand Strategy
- 12.2.3 Target Client
- 12.3 Distributors/Traders List
13 Market Effect Factors Analysis
- 13.1 Technology Progress/Risk
- 13.1.1 Substitutes Threat
- 13.1.2 Technology Progress in Related Industry
- 13.2 Consumer Needs/Customer Preference Change
- 13.3 Economic/Political Environmental Change
14 Global Neuroprotection Market Forecast (2018-2025)
- 14.1 Global Neuroprotection Sales Volume, Revenue and Price Forecast (2018-2025)
- 14.1.1 Global Neuroprotection Sales Volume and Growth Rate Forecast (2018-2025)
- 14.1.2 Global Neuroprotection Revenue and Growth Rate Forecast (2018-2025)
- 14.1.3 Global Neuroprotection Price and Trend Forecast (2018-2025)
- 14.2 Global Neuroprotection Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
- 14.2.1 Global Neuroprotection Sales Volume and Growth Rate Forecast by Regions (2018-2025)
- 14.2.2 Global Neuroprotection Revenue and Growth Rate Forecast by Regions (2018-2025)
- 14.2.3 United States Neuroprotection Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
- 14.2.4 China Neuroprotection Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
- 14.2.5 Europe Neuroprotection Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
- 14.2.6 Japan Neuroprotection Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
- 14.2.7 Southeast Asia Neuroprotection Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
- 14.2.8 India Neuroprotection Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
- 14.3 Global Neuroprotection Sales Volume, Revenue and Price Forecast by Type (2018-2025)
- 14.3.1 Global Neuroprotection Sales Forecast by Type (2018-2025)
- 14.3.2 Global Neuroprotection Revenue Forecast by Type (2018-2025)
- 14.3.3 Global Neuroprotection Price Forecast by Type (2018-2025)
- 14.4 Global Neuroprotection Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology/Research Approach
- 16.1.1 Research Programs/Design
- 16.1.2 Market Size Estimation
- 16.1.3 Market Breakdown and Data Triangulation
- 16.2 Data Source
- 16.2.1 Secondary Sources
- 16.2.2 Primary Sources
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
